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VP26 is the smallest capsid protein of herpes simplex virus type 1 and is encoded by the UL35 open reading frame. It
resides on the outer capsid surface, interacting with VP5 in a one to one stoichiometry in the hexons that comprise capsids.
A null mutation in the gene encoding VP26 was generated and transferred into the KOS genome. Recombinant viruses were
isolated on Vero cells, which indicated that the absence of VP26 was not required for growth of the virus in cell culture. This
was confirmed by the characterization of the VP26 null mutant, designated KD26Z. The yield of virus from KD26Z-infected
Vero cells was decreased only twofold relative to wild-type-infected cells, as judged by the burst size. All three types of
capsids (A, B, and C) were observed after sedimentation analysis of KD26Z-infected cell extracts. These capsids were similar
in composition to wild-type capsids except for the absence of VP26. The mouse ocular model was used to determine if VP26
played a major role in vivo. The yield of the mutant virus relative to wild-type virus was decreased twofold in the eye; however,
the mutant virus yields were decreased 30- to 100-fold in the trigeminal ganglia. Reactivation of the mutant virus as
determined by cocultivation assays was also reduced. To determine the effect of VP26 on capsid translocation, the VP26 null
mutation was transferred into a virus specifiying a thymidine kinase mutation that by itself is transported to the trigeminal
ganglia but whose DNA is not replicated in the ganglia. Using quantitative PCR assays the number of viral genomes detected
in the ganglia was similar in the presence or the absence of VP26. Therefore, VP26 does not appear to aid in the translocation
of the virus capsid from the mouse eye to the trigeminal ganglia but is important for infectious virus production in the ganglia.
© 1998 Academic Press
INTRODUCTION
The herpes simplex virus type 1 (HSV-1) genome is
enclosed in an icosahedral proteinaeous capsid (Wildy
et al., 1960). Three types of capsids can be isolated from
HSV-1-infected cells. They are visualized as light scat-
tering bands in sucrose gradients and are designated A,
B, and C, in order of increasing distance sedimented
(Gibson and Roizman, 1972). They differ in protein and
DNA composition and in their eventual fate in the in-
fected cell. A and C capsids are similar in protein con-
tent, but only the C capsid contains a genomic equivalent
of DNA and presumably matures into the infectious virion
(reviewed in Roizman and Sears, 1996). The B capsid is
composed of seven proteins. Their designations, and the
open reading frames (ORF) encoding the proteins, are:
VP5 (UL19), VP19C (UL38), 21 (UL26), 22a (UL26.5), VP23
(UL18), VP24 (UL26), and VP26 (UL35) (Gibson and Roiz-
man, 1972; Heilman et al., 1979; Cohen et al., 1980;
McGeoch et al., 1988). VP5 is the major capsid protein,
comprises approximately 60% of the capsid mass, and
forms the hexons and pentons present in capsids. Pro-
tein 22a is present only in B capsids, occupies the inner
capsid space, and functions as a scaffold for assembly of
the icosahedral capsid shell. VP19C and VP23 form a
triplex structure that is required to form and stabilize the
capsid shell. The UL26 gene products encode an essen-
tial protease activity, VP24, specified by residues 1 to
247, and protein 21, specified by residues 248 to 635.
Protein 21 shares sequence identity with the more abun-
dant 22a from residues 307 to 635 and also has scaffold
activity (reviewed in Steven and Spear, 1996).
VP26 is the smallest capsid protein (12 kDa) and is
encoded by the UL35 ORF (McNabb and Courtney,
1992a; Davison et al., 1992). It is expressed late in the
infectious cycle after the onset of DNA replication and
has been shown to be present in multiple phosphory-
lated forms (McNabb and Courtney, 1992b). It localizes to
the infected cell nucleus (McNabb and Courtney, 1992b)
and requires the presence of VP5 for this localization in
transfected cells (Rixon et al., 1996). There are approxi-
mately 900 copies of this molecule and they occupy the
tips of the hexons but not pentons (Booy et al., 1994; Trus
et al., 1995; Wingfield et al., 1997; Zhou et al., 1995).
Although it interacts with VP5, it is not required for capsid
formation in a baculovirus expression system (Tatman et
al., 1994; Thomsen et al., 1994).
A characteristic feature of HSV-1 replication is the
ability to establish lifelong latent infections (reviewed
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in Wildy et al., 1982). Infection at a peripheral site
results in the replication of virus in these cells. Virus is
taken up by neuritic extensions and the nucleocapsid
and associated proteins are translocated intraxonally
to the neuronal cell nuclei in the trigeminal ganglia
(Cook and Stevens, 1973). Virus replication also oc-
curs in the trigeminal ganglia with the concomitant
destruction of those cells; however, some cells retain
the virus in a latent state. Reactivation occurs upon
appropriate stimulation and results in the synthesis of
virus progeny and transport of virus particles back to
the site of the initial infection. Of the more than 70
gene products specified by the virus genome, approx-
imately half of these are not required for the replica-
tion of the virus in cell culture. These gene products
may specify functions that are required for the efficient
replication and spread of the virus in the host animal
(reviewed in Ward and Roizman, 1994).
Null mutant viruses have been isolated for genes en-
coding VP5 (UL19), VP23 (UL18), and VP19C (UL38) and
for UL26 and UL26.5 (VP24, 21, and 22a) and all require
the expression of the indicated gene products for prop-
agation (Desai et al., 1993, 1994; Gao et al., 1994; Matu-
sick-Kumar et al., 1994; Person and Desai, 1998). There-
fore, all of these proteins are essential for virus replica-
tion. This report describes the isolation of a null mutant
in UL35 (VP26). When this study was undertaken the
function of VP26 and its role in the infectious cycle was
unknown. Results presented below show that VP26 is
dispensable for replication in cell culture. Capsid assem-
bly and the composition of the virions synthesized ap-
pear to be unaffected by the absence of VP26, although
infectious virus yield is decreased by twofold relative to
wild-type. Therefore, VP26 is the only capsid protein that
is not required for replication in cell culture. However,
studies presented below show that it is important for
virus replication in vivo.
RESULTS
Construction and isolation of a null mutation in the
gene encoding VP26 (UL35)
The goal of the experiments reported here was to
isolate a null mutant in the smallest capsid protein, VP26.
Plasmid pKELDNN, which encodes the entire UL35 ORF
(VP26) (McGeoch et al., 1988) and the flanking se-
quences necessary for recombination into the virus ge-
nome, was used for this construction and is depicted in
Fig. 1. Overlap extension PCR was used to delete 280 bp
in the UL35 ORF, which resulted in the deletion of VP26
codons 10 to 102, of a total of 112 codons (Fig. 1). This
procedure also introduced a unique XhoI site at the site
of the deletion. A XhoI lacZ cassette was introduced into
this site in frame with the VP26 coding region and this
plasmid was designated pKD26Z (Fig. 1). Expression of
LACZ is driven by the UL35 gene promoter and transla-
tion initiation occurs at the VP26 ATG. b-Galactosidase
expression was used to identify viruses containing the
null mutation.
Since VP26 is not required for capsid formation in
recombinant baculovirus-infected insect cells (Tatman et
al., 1994; Thomsen et al., 1994) isolation of the VP26 null
mutant utilized nontransformed Vero cells. Vero cell
monolayers were cotransfected with KOS viral DNA and
linearized pKD26Z. The progeny virus from the cotrans-
fection were plated on Vero cell monolayers with a Bluo-
gal overlay. Blue plaques were observed in the transfec-
tion progeny at a frequency of between 1 and 5%. A
number of such plaques were picked. Two isolates
which were highly enriched for ‘‘blue’’ viruses were puri-
fied further and both were shown to contain the UL35
deletion (see below). These plaques also tended to be
smaller in size than wild-type plaques. A presumptive
null mutant (isolate 2) was designated KD26Z. A marker-
rescued virus, designated K26R, was obtained after co-
transfection of cells with KD26Z virus DNA and the pKEL
plasmid. This plasmid encodes the EcoRI L region of
FIG. 1. Construction of a null mutation in the UL35 gene encoding
VP26. The EcoRI L fragment encodes UL35 (VP26) and the C-terminal
sequences of the UL34 and UL36 genes (McGeoch et al., 1988). The
relevant restriction sites are shown at the top of the figure for EcoRI (E),
HpaI (H), NruI (N), NotI (Nt), and NcoI (Nc). Plasmid pKELDNN was
deleted for sequences spanning the NotI to NcoI restriction sites for
purposes of PCR reactions and subsequent cloning. Primers used for
the overlap PCR reactions are shown (P1 to P4). The PCR products
generated by amplification with primers P1 and P2 and with primers P3
and P4 were annealed together by virtue of complementary sequences
located at the ends of P2 and P3 (thickened line) which also specified
a XhoI restriction site. P1 and P4 were then used to amplify the
annealed fragment and this was cloned back into pKELDNN as a HpaI
to NruI fragment. The UL35 codons 10 to 102 were replaced with an
XhoI site and a lacZ cassette was cloned into the XhoI site to generate
pKD26Z.
116 DESAI, DELUCA, AND PERSON
KOS (see Fig. 1). K26R formed large colorless plaques in
a Bluo-gal overlay. DNA extracted from virus-infected
cells was analyzed by Southern blot hybridization (Fig. 2).
For K26DZ, there was an overall insertion of 2.7 kb
(deletion of 282 bp of the UL35 ORF and the addition of
the 3-kb lacZ fragment). The probe hybridized to the
5.2-kb EcoRI L fragment in KOS DNA (lane 1), which was
cleaved into 4.2- and 3.7-kb fragments in KD26Z DNA
(lane 2) due to the presence of an EcoRI site in the lacZ
gene. The 7.5-kb XhoI fragment observed in KOS DNA
(lane 4) was cleaved into 4.4- and 2.8-kb fragments in
KD26Z DNA (lane 5) due to the presence of the XhoI site
at the site of the deletion. The lacZ (3-kb) fragment
hybridized weakly to the probe (see band above 2.8 kb,
lane 5) since pUC19 contains only approximately 200 bp
of lacZ sequence. The result of the Southern blot con-
firmed the introduction of the plasmid-specified deletion
into the UL35 ORF. This virus was able to form plaques
on Vero cells and therefore, VP26 is not essential for
virus replication in cell culture. The hybridization pattern
of K26R (lanes 3 and 6) was identical to that of wild-type
DNA, indicating that the UL35 deletion had been rescued
in this virus.
To further confirm the introduction of the UL35 muta-
tion into virus, radiolabeled infected cell extracts were
examined for the presence of the VP26 polypeptide in
both wild-type and mutant infected cells. Vero cells were
infected with KOS, K26DZ, and K26R and metabolically
labeled with [35S]methionine. Protein lysates were pre-
pared and reacted with a peptide antiserum raised to the
C-terminus of the VP26 protein. The resulting immuno-
precipitates were resolved by sodium dodecyl sulfate–
polyacrylamide gel electrophoesis (SDS–PAGE), the re-
sult of which is shown in Fig. 3. A 12-kDa polypeptide
corresponding to VP26 was detected in KOS (lane 1)- and
K26R (lane 3)-infected cell extracts; however, this protein
was absent in KD26Z (lane 2) extracts. Therefore, the null
mutation in KD26Z abrogates the synthesis of the VP26
polypeptide.
VP26 is not essential for virus replication
in cell culture
The ability to isolate a VP26 null mutant on Vero cells
indicated that VP26 was not an essential component of
the virion. However, the KD26Z plaques on Vero cells
were smaller in size than those of wild-type. Therefore,
Vero cell monolayers were infected at an M.O.I. of 10
PFU/cell and harvested 24 h later and virus yields deter-
mined. KOS gave a burst size of 900 PFU/cell, whereas
KD26Z gave a burst of 450 PFU/cell (average of three
experiments). The yield of physical particles obtained
from KD26Z-infected cells was also decreased by ap-
proximately twofold relative to KOS, as judged by sedi-
mentation analysis of intracellular virus particles (data
not shown). This observation presumably accounts for
the decreased infectivity obtained from the mutant in-
fected cells.
Capsid formation in KD26Z-infected cells
Experiments carried out using baculovirus-expressed
capsid proteins have shown that VP26 is not required for
B capsid formation in insect cells (Tatman et al., 1994;
Thomsen et al., 1994). These studies could not address
the issue of the requirement of VP26 for C capsid ma-
turation or DNA packaging. To examine capsid forma-
tion, HEL cells were infected with both KOS and KD26Z
and metabolically labeled with [35S]methionine. Nuclear
extracts were sedimented through sucrose gradients.
Fractions collected after sedimentation were analyzed by
SDS–PAGE, the results of which are shown in Fig. 4. The
direction of sedimentation is from left to right. Three
peaks of radioactivity were detected for KOS (Fig. 4A)-
and KD26Z (Fig. 4B)-infected cell extracts corresponding
to the faster sedimenting C capsids (fraction 11) and the
slower B (fraction 7) and A capsids (fraction 5). The
amounts of the capsid proteins observed for KOS and for
KD26Z were similar, except for VP26.
FIG. 3. Immunoprecipitation of VP26 from infected cell extracts. Vero
cell monolayers (1 3 106 cells) were infected at a M.O.I. of 10 PFU/cell
with KOS (lane 1), KD26Z (lane 2), and K26R (lane 3) and metabolically
labeled with [35S]methionine from 8 to 24 h postinfection. Extracts
prepared were immunoprecipited with a peptide antiserum to VP26.
The resulting immuneprecipitates were analyzed by SDS–PAGE (17%
polyacrylamide gel).
FIG. 2. Southern blot analysis of the KD26Z genome. 2 mg of KOS
(lanes 1 and 4), KD26Z (lanes 2 and 5), and K26R (lanes 3 and 6) viral
DNA was digested with either EcoRI (lanes 1 to 3) or XhoI (lanes 4 to
6) and the resulting fragments resolved by agarose gel electrophoresis
and analyzed by Southern blot hybridization. Filters were hybridized
with a 32P-labeled DNA probe corresponding to plasmid pKEL (EcoRI L
fragment of KOS cloned into pUC19).
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VP26 is important for production of infectious virus in
trigeminal ganglia
HSV-1 encodes for a number of gene products that
function in DNA metabolism and replication and struc-
tural components of the virus which are not necessary
for the replication of the virus in cell culture but manifest
their effects in vivo (reviewed by Ward and Roizman,
1994). The goal of the experiments described below was
to determine whether VP26 exhibits a similar phenotype.
The mouse eye model is routinely used to investigate
the pathogenesis of HSV-1 mutants (Leib et al., 1989).
CD-1 mice are infected with virus following corneal scar-
ification. Replication in the eye ensues and high levels of
virus titers are detected in eye swabs 24 h after infection.
Normally virus particles undergo a round of replication in
the eye and nucleocapsids are transported intraaxonally
to the trigeminal ganglia. Virus replication also occurs in
the trigeminal ganglia, with peak titers observed 3 days
after infection. The levels of virus in the trigeminal gan-
glia begin to decline after 5 days and little or no virus is
detected 7 days after infection (Leib et al., 1989).
Six-week-old CD1 mice were infected with 2 3 106
PFU per eye of KOS, KD26Z, and K26R, following bilateral
scarification of the cornea. Twenty-four hours later eye
swabs were performed to determine the replication of
virus in the eye. The numbers of PFU/ml in the eye swabs
were determined following titration on Vero cells (Table 1).
KOS titers were similar to those reported by Strelow and
Leib (1995). KD26Z virus replication in the eye detected
24 h after infection was down twofold relative to that of
wild-type (Table 1). This mirrored the replication ob-
served in cell culture.
In preliminary experiments, KD26Z virus titers were
greatly decreased in the trigeminal ganglia at 72 h
postinfection. To determine the kinetics of KD26Z infec-
tions in the trigeminal ganglia, a time course experiment
was carried out. Mice were infected with 2 3 106 PFU
per eye and virus titers determined from trigeminal gan-
glia homogenates at 2, 3, 4, 5, and 7 days after infection
(Table 2). Virus titers 6 1 SD are given in the table, along
with the number of ganglia, of the total number, that gave
rise to infectious virus. KOS titers were highest on day 3
and decreased thereafter. KD26Z virus titers increased
until day 5 but never approached the maximum titer for
KOS. The maximum titer for the mutant virus (day 5) was
3.3 3 103 compared with 1.3 3 105 for KOS (day 3), or
2.5% of that of the wild-type virus. K26R results were
similar to those for KOS (data not shown).
Latency and reactivation
In order to determine whether KD26Z could establish
latent infections and whether it can reactivate from such
infections, mice were infected with KOS, KD26Z, and
K26R. Ganglia were explanted 32 days postinfection.
Reactivation was monitored by explant cocultivation as-
says on Vero cell monolayers. DMSO was included in the
medium for KD26Z ganglia to determine if it resulted in
an increase in reactivation, as has been observed for
other viruses (Leib et al., 1989). Reactivation was de-
tected in all 18 of the KOS-infected ganglia and 6 of 8
K26R-infected trigeminal ganglia. However, KD26Z-in-
fected ganglia reactivated at a low frequency; 5 of 24
ganglia produced virus. This could be due to the low
levels of virus detected in the ganglia during the acute
phase, which resulted in fewer cells establishing latent
infections. However, the presence of DMSO resulted in
an enhanced frequency of reactivation; 6 KD26Z-infected
ganglia were treated with DMSO and all 6 gave rise to
TABLE 1





1 7.1 3 104 2.5 3 104 38
2 2.3 3 105 1.3 3 105 57
3 1.1 3 106 4.6 3 105 42
FIG. 4. Sedimentation analysis of infected cell nuclear extracts. HEL
cell monolayers (2 3 107 cells) were infected with KOS (A) and KD26Z
(B) at an M.O.I. of 10 PFU/cell and labeled with [35S]methionine from 8
to 24 h postinfection. Nuclear extracts were prepared and layered onto
20–50% sucrose gradients. Fractions collected after sedimentation
were TCA precipitated and analyzed by SDS–PAGE (17% polyacryl-
amide gel). Fraction 1 corresponds to the top of the tube. Protein
molecular weight standards are shown in lane M and correspond to
200, 97.4, 68, 43, 29, 18.4, and 14.3 kDa, respectively. The position of the
capsid proteins is indicated on the left of the figure for KOS.
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virus. DMSO enhances reactivation, perhaps by conver-
sion of latent viral DNA into a transcriptionally active
form (Whitby et al., 1987). Therefore, even if fewer cells
were latently infected, the presence of DMSO increased
the ability to detect reactivatable virus.
PCR DNA analysis of virus genomes in mouse
trigeminal ganglia
A plausible explanation for the decreased number of
PFU per ganglion observed for KD26Z infections may be
that VP26 promotes capsid transport within the cell.
HSV-1 nucleocapsids are actively transported through
axons along microtubules to the cell body of the neuron
(Kristensson et al., 1986; Sodeik et al., 1997; Topp et al.,
1994). Presumably, interactions between virion proteins
and microtubular-associated proteins are required for
this movement. Since VP26 is located on the surface of
the capsid shell (Booy et al., 1994; Trus et al., 1995;
Wingfield et al., 1997; Zhou et al., 1995) it would appear to
be a likely candidate for this interaction. It was postu-
lated that if VP26 mediates transport of the capsid struc-
ture along microtubules, its absence may result in a
significant reduction in the ability of the capsid to be
transported to the sensory ganglia and hence decreased
virus yields in the trigeminal ganglia of mice.
To determine if VP26 is a translocation protein the
mouse ocular model was used to measure the transport
of the virus particle between two distal sites. PCR assays
performed on DNA extracted from infected trigeminal
ganglia can be used as a measure of translocation of
viral genomes. The assays were performed according to
the protocols described by Coen (1990a,b), Katz et al.
(1990), and Strelow and Leib (1995).
Mice were infected with KOS and KD26Z as de-
scribed above, and trigeminal ganglia harvested 72 h
after infection. DNA was extracted from the tissue,
samples were pooled, and PCR assays were per-
formed using oligonucleotides specific for the HSV-1
gene encoding VP16 and for the host gene encoding
adipsin, which is a single copy mouse gene that
serves as an internal control. The level of amplification
was determined by hybridization of the PCR products
with 32P end-labeled oligonucleotides that bind to
HSV-1 (VP16)- or cellular (adipsin)-specific DNA se-
quences. Results are shown in Fig. 5A for mock-in-
fected (lane 1) and KOS-infected (lane 2) ganglia and
for two independent infections with KD26Z (lanes 3
and 4). The levels of viral DNA in KD26Z-infected
trigeminal ganglia were decreased slightly relative to
those of KOS-infected ganglia (compare lane 2 to
lanes 3 and 4). The levels of adipsin DNA detected in
all the samples were similar (Fig. 5B). Similar results
were observed when DNA was analyzed from trigem-
inal ganglia harvested 36 and 48 h postinfection (data
not shown). Thus, the decrease in the number of
genomes for KD26Z relative to KOS does not reflect the
30- to 100-fold decrease in infectivity observed above.
TABLE 2




of KOSITG/TG PFU/ml ITG/TG PFU/ml
2 1/4 2.3 6 1.5 3 103 1/4 7.0 6 8.4 3 101 3.0
3 15/18 1.3 6 1.1 3 105 10/18 8.9 6 3.3 3 102 0.7
4 3/4 5.1 6 2.3 3 104 2/4 1.3 6 1.2 3 103 2.5
5 8/8 2.3 6 1.5 3 104 6/8 3.3 6 1.8 3 103 14.0
7 4/8 1.1 6 1.1 3 103 3/8 1.1 6 3.3 3 101 1.0
Note. Day p.i., days postinfection; ITG/TG, number of infected trigeminal ganglia yielding virus/total number of trigeminal ganglia harvested. PFU/ml,
average of PFU/ml from ganglia that gave rise to infectious virus divided by the total number of ganglia. Percent of KOS, % of KD26Z virus yield relative
to KOS titers.
FIG. 5. PCR analysis of DNA from infected trigeminal ganglia. DNA
extracted from trigeminal ganglia 3 days after infection were subjected
to PCR assays using primers specific to viral VP16 gene (A) or the
single copy host gene, adipsin (B). The PCR products were resolved on
an 8% nondenaturing polyacrylamide gel and transferred to nylon
membranes. Membranes were hybridized with 32P end-labeled oligo-
nucleotides corresponding to the internal sequences of the amplified
products. Results are shown for ganglia infected with KOS (lanes 2),
two independent infections for KD26Z (lanes 3 and 4), and mock-
infected ganglia (lanes 1). Data presented was derived by assaying
pooled DNA samples from three mice for each virus.
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Determination of the number of viral genomes per
trigeminal ganglion in the absence of DNA replication
Data presented in Fig. 5 showed that the amount of
KD26Z viral DNA in the ganglia at 72 h postinfection
was only slightly reduced relative to that of KOS. For
wild-type viruses, considerable DNA and viral replica-
tion occurs in the trigeminal ganglia. It is likely that
KD26Z also undergoes DNA replication in ganglia. In
order to evaluate capsid translocation in the absence
of DNA replication, the KD26Z mutation was intro-
duced into the background of a thymidine kinase (TK)
deletion mutant (dlsactk), kindly provided by Dr.
Donald Coen. It has been shown that the absence of
TK has no appreciable effect on virus replication in
cell culture; however, it is severely impaired for repli-
cation in trigeminal ganglia (Coen et al., 1989). TK-
negative viruses replicate in the eye and are trans-
ported to the trigeminal ganglia normally (Kramer et
al., 1998). A determination of the number of genomes
per ganglion for a double mutant virus compared with
the number for dlsactk may reveal the requirement, if
any, of VP26 for capsid translocation. This strategy
allows the number of genomes translocated to be
determined in the presence and the absence of VP26
and more importantly in the absence of replication of
genomes after translocation.
The double mutant virus, designated dlsactk/KD26Z,
encoding both the UL35 and TK mutations was obtained
after co-infection of Vero cells followed by screening
individual plaques for phenotypic markers indicative of
the two mutations (see Materials and Methods). Mice
were infected with KOS, KD26Z, dlsactk, and dlsactk/
KD26Z or mock-infected. Three mice were used for each
virus and the trigeminal ganglia harvested 3 days after
infection. DNA was extracted from the tissue, samples
were pooled, and PCR assays were performed as de-
scribed above. A standard curve was generated using
HSV-1 DNA to establish the number of HSV-1 genomes
per ganglion (Figs. 6A and 6B). For the standard curve,
mouse DNA from mock-infected ganglia was spiked with
known amounts of viral DNA (Katz et al., 1990). Data are
plotted as log of the autoradiographic signal as a func-
tion of the number of copies of HSV-1 DNA per cell. The
number of genomes per cell was determined using a
value of 106 cells per ganglion (Katz et al., 1990). Ampli-
fication of the VP16 PCR product was linear from 0.01 to
10 copies per cell. PCR assays were then performed for
the DNA extracted from infected ganglia using both the
VP16 and the mouse adipsin primers. Data for mock-
infected (lanes 1) and KOS (lanes 2)-, KD26Z (lanes 3)-,
dlsactk (lanes 4)-, and dlsactk/KD26Z (lanes 5)-infected
mice are shown in Figs. 6C and 6D. The level of adipsin
detected, the internal control, was similar in all of the
experiments. Therefore, a visual comparison of the data
shown in Figs. 6A and 6C was sufficient to see the major
results. At 72 h postscarification of mouse eyes the
number of copies of KOS and KD26Z genomes per cell
were between between 1 and 10 . The signals for dlsactk
in the presence and the absence of VP26 were similar to
each other and were present at approximately 0.01 cop-
ies per cell. Using the standard curve the number of
genomes per mouse cell equivalent was 4.2 for KOS, 2.5
for KD26Z, 0.018 for dlsactk, and 0.011 for dlsactk/KD26Z.
FIG. 6. Quantitative PCR analysis of DNA from infected trigeminal
ganglia. DNA extracted from trigeminal ganglia 3 days following infec-
tion were subjected to PCR assays using primers specific to viral VP16
gene (A and C) or the single copy host gene, adipsin (D). The PCR
products were analyzed as described in the legend to Fig. 5. (A)
Quantitative DNA PCR assay of mock-infected trigeminal ganglia DNA
spiked with HSV DNA corresponding to 10, 1, 0.1, and 0.01 copies of
viral genomes per mouse cell equivalent. (B) Standard curve of the
VP16 PCR signal corresponding to 10 to 0.01 copies of HSV genomes
per mouse cell equivalent. (C) PCR amplification of the VP16 product
from trigeminal ganglia DNA extracted from mock-infected mice (lane
1) or those infected with KOS (lane 2), KD26Z (lane 3), dlsactk (lane 4),
or dlsactk/KD26Z (lane 5). (D) PCR amplification of the adipsin product
from trigeminal ganglia DNA extracted from mock-infected mice (lane
1) or those infected with KOS (lane 2), KD26Z (lane 3), dlsactk (lane 4),
or dlsactk/KD26Z (lane 5). Data presented were derived by assaying
pooled DNA samples. The numbers were derived from the average of
data for six ganglia in a single experiment. The autoradiograhic signal
from the filters was quantified in a Phosphoimager (FUJIX BAS 1000).
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Finally, Southern blot analysis of DNA extracted from
trigeminal ganglia 3 days after infection revealed that the
structure of the KD26Z genome was characteristic of
packaged virus DNA; that is, the ratio of the junction and
terminal fragments detected was comparable to the ratio
observed for wild-type DNA (data not shown). This may
indicate that the decreased infectivity in ganglia occurs
after DNA packaging. Therefore, the presence of VP26
may serve to increase the infectivity of virus particles
formed in the neuronal cell.
DISCUSSION
VP26 is one of the smallest structural virion proteins of
herpes simplex viruses. It is present in the capsid at 900
copies per capsid and is located on the surface of the
capsid shell. When this study was initiated the role of
VP26 in capsid assembly and virus replication had yet to
be characterized. A null mutant in UL35 (VP26) was
isolated by deletion of the majority of the coding se-
quences followed by the insertion of the lacZ gene. Blue
plaques were observed on the nontransformed Vero cell;
this result together with data from single-step growth
experiments indicated that the absence of this gene
product does not have a detrimental effect on the repli-
cation of the virus in cell culture. The only detectable
phenotype of this mutant in tissue culture was the de-
creased yield of virion particles, as judged by sedimen-
tation analysis and the consequent twofold decreased
yield of infectious virus from cells.
Replication of the VP26 null mutant virus in vivo was
more dramatically affected. Whereas the virus repli-
cated in the eye at levels comparable to those seen in
cell culture, the yield of infectious virus from the tri-
geminal ganglia was decreased by 100-fold in some
cases. This reduction was also observed at earlier
times in the infection of the trigeminal ganglia. Never-
theless, the absence of VP26 does not affect the ability
of the virus to establish latent infections as judged by
the detection of reactivatable virus in the presence of
DMSO. A more striking reduction in the formation of
infectious particles in vivo has been observed for other
HSV-1 gene functions, notably ribonucleotide reduc-
tase and thymidine kinase (Coen et al., 1989; Jacobson
et al., 1989). In cell culture, host cell factors can com-
pensate for the absence of the virus-specified func-
tion. However, in nondividing cells of the trigeminal
ganglia the absence of these compensatory host fac-
tors results in a requirement of the virus-specified
function for replication to proceed. This phenomenon
is more applicable to enzymatic functions such as
thymidine kinase and ribonucleotide reductase, which
have similar host counterparts, than for a structural
protein such as VP26. Nevertheless, VP26 should be
added to the list of virus functions that are classified
as accessory functions; that is, they are not required in
an artificial system such as tissue culture but play an
important role in the replication of the virus in vivo.
Kramer et al. (1998) have reported the kinetics of ac-
cumulation of the number of copies of HSV-1 genomes
per ganglion from 20 to 72 h postinfection for wild-type
(KOS) virus and for the dlsactk mutant. From their graph
at 72 h the average values are 3.5 3 106 genomes per
ganglion for KOS and 8 3 103 for dlsactk. Assuming 106
cells per ganglion these numbers correspond to 3.5 and
to 0.008 copies per mouse cell equivalent, respectively.
In the single experiment reported here we obtained 4.2
genomes per cell for KOS and 0.018 for dlsactk. At 72 h
postinfection, essentially all of the signal for KOS, and for
the VP26 null mutant, was due to viral DNA replication
following translocation of capsids to the trigeminal gan-
glia. The number of genomes per cell for the double
mutant dlsactk/KD26Z was 0.011 and was similar to that
for dlsactk. Although the data presented are from a
single experiment, there was no evidence for a capsid
translocation function by VP26. The number of genomes
in ganglia was the same in the presence and in the
absence of VP26 in the dlsactk background.
An intriguing question is how VP26 influences infec-
tious particle production in the neuronal cell. VP26 is
located on the surface of the capsid and one can envi-
sion that it would interact with the viral tegument com-
ponents during virion maturation. The tegument consists
of numerous gene products which encode for both es-
sential and nonessential functions with respect to repli-
cation in cell culture. Some of the components of tegu-
ment that specify nonessential functions may be impor-
tant for the replication of the virus in vivo. Although an
analysis of the virion polypeptides of KOS and KD26Z did
not reveal any significant differences between the two
virion types, with regard to composition and quantity of
virion polypeptides, it is possible that the incorporation of
minor components of the tegument was affected by the
absence of VP26. This may not result in a detectable
phenotype in cell culture, but it may alter the replication
of the virus in vivo.
MATERIALS AND METHODS
Cells and viruses
Vero cells and human embryonic lung (HEL) cells were
grown in Eagle’s minimum essential medium supple-
mented with 10% fetal calf serum (GIBCO-BRL). Flasks
(1500 mm2) were seeded with either 3.5 3 106 Vero or
4 3 106 HEL cells and the cells harvested and reseeded
every 2 days (Vero) or every 3 days (HEL).
Virus stocks were prepared by infecting 1 3 108 Vero
cells at a multiplicity of infection (M.O.I.) of 0.01 PFU/cell.
Three days following infection both the intracellular and
extracellular viruses were harvested and concentrated
by centrifugation prior to titration. Virus dlsactk was
kindly provided by Dr. Donald Coen of Harvard Medical
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School (Coen et al., 1989). The double mutant dlsactk/
KD26Z was obtained by coinfection of Vero cells (1 3 106
cells in 35-mm-diameter dishes) with KD26Z and dlsactk
at a M.O.I. of 3.0 PFU/cell and harvested 14 h later.
Recombination between the two parental DNAs would
result in wild-type virus and a virus containing both
mutations. A lacZ cassette had been inserted into the
ORF specifying VP26. Therefore plaques representing
KD26Z and the double mutant virus stained blue in a
Bluo-gal (GIBCO-BRL) overlay. DNA from a number of
such viruses was digested with SacI to identify the thy-
midine kinase (TK) mutation (Coen et al., 1989). One
virus, designated dlsactk/KD26Z, was purified further
and analyzed by Southern blot hybridization (data not
shown), which confirmed the introduction of both the
UL35 (VP26) and UL23 (TK) mutations into the HSV-1
genome.
Plasmids
Plasmid pKEL contains the 5.2-kb EcoRI L fragment of
the KOS genome (map units 0.522–0.571) cloned into
pUC19 and encodes the UL35 ORF (see Fig. 1) (Mc-
Geoch et al., 1988). This plasmid was shortened by
digestion with NotI and NcoI, the overhangs were filled
in with Klenow enzyme and then blunt end ligated with a
HindIII linker (10-mer, NEB). This plasmid , deleted for
2.46 kb of the UL36 ORF present in pKEL, was desig-
nated pKELDNN.
A deletion in the UL35 ORF was generated by the
procedure of PCR overlap extension (Ho et al., 1989). For
this experiment four primers were used: primer 1 (ACG-
GTTTTGGCCCGCTCCCCT), primer 2 (TCTATAGCCTTGG-
CTCGAGCCGGGGCGGTGAAATTG), primer 3 (GGCTCG-
AGCCAAGGCTATAGATTCGAGAACCTTCGA), and primer
4 (ACGCGCTTACAATTCGGCCCC). Primer 1 binds to
sequences in the 5’ flanking region of the UL35 gene,
upstream of the HpaI site (Fig. 1), whereas primer 2
anneals to sequences at the N-terminus of the UL35
ORF, codons 5 to 9, and also specifies an XhoI restric-
tion site (underlined sequences in primers 2 and 3).
Primer 3 anneals to the UL35 gene sequence specifiy-
ing codons 103 to 108 at the C-terminus and contains
an XhoI restriction site, and primer 4 binds to se-
quences in the 3’ flanking region of the UL35 gene
downstream of the NruI site (Fig. 1). Primers 2 and 3
contain complementary 21-bp sequences which in-
clude the XhoI restriction recognition sequence. The
PCR products generated by experiments using prim-
ers 1 and 2 and primers 3 and 4 can be annealed
together by virtue of this 21-bp sequence and a PCR
product of the annealed fragments can be generated
by using primers 1 and 4, resulting in the deletion of
the internal UL35 sequence (codons 10 to 102).
PCR reactions were performed with 100 ng of lin-
earized pKELDNN and either primer pairs 1 and 2 or 3
and 4. The reactions were carried out using Deep Vent
DNA polymerase (NEB). The reaction mixtures were
initially subjected to a denaturation step at 99°C for
30 s and then cycled 20 times, each cycle consisting of
a 5-s denaturation step at 99°C, followed by annealing
at 42°C for 1 s, and extension at 72°C for 20 s. The
resulting 350-bp (using primers 1 and 2) and 400-bp
(using primers 3 and 4) PCR products were purified,
mixed together in equal amounts, and used in the PCR
overlap extension reaction. The reaction conditions
were the same as described above except for the
primers (P1 and P4). The full-length product was gel
purified, digested with NruI and HpaI, and ligated into
a pKELDNN vector similarly digested with NruI and
HpaI. The resulting plasmid was designated pKD26.
DNA sequence analysis was carried out in the 59 and
39 flanking regions, and in the 59 coding region, of
UL35 and was identical to KOS sequences in the same
region (Sequenase 2.0, USB). The lacZ ORF derived
from pSC8 as a XhoI cassette (Chakrabarti et al., 1985)
was cloned into the XhoI site of pKD26 to give pKD26Z.
Antibodies
Peptide antisera to the UL35 ORF were generated in
rabbits (Research Genetics). The peptide used for the
antigen was a C-terminal peptide spanning residues 95
to 112 of UL35.
Marker transfer of the null mutation
Marker transfer of the null mutation was essentially
carried as described in Person and Desai (1998). Prog-
eny virus from the transfection were tested for their
ability to expresss the lacZ gene as described in Desai
et al. (1993). Viruses that formed blue plaques were
picked, further purified, and characterized. These vi-
ruses generally formed plaques of smaller size than
KOS. One such isolate was plaque purified three times
and designated KD26Z. The UL35 rescued virus (K26R)
was similarly generated by cotransfection of Vero cells
with KD26Z genomic DNA and plasmid pKEL. Virus
plaques were isolated from the transfection progeny
that resembled wild-type virus, that is, larger plaque
size and the absence of b-galactosidase expression.
Viruses that exhibited this phenotype were further
purified and characterized.
Southern blot hybridization
DNA sequences were detected after agarose gel elec-
trophoresis as described by Southern (1975), using ran-
dom-primer-labeled probes (Boehringer-Mannheim).
Radiolabeling, immunoprecipitation, and SDS–PAGE
Radiolabeling of infected cells, immunoprecipitation
experiments, and SDS–PAGE analysis were performed
as described in Person and Desai (1998).
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Sedimentation analysis of capsids
Sedimentation analysis of capsids from radiolabeled
nuclear extracts derived from HEL-infected cells was
performed as described in Desai et al. (1993) and Person
and Desai (1998).
Animal procedures
Animal procedures were performed according to the proto-
cols used by Leib et al. (1989). Six-week-old CD-1 mice
(Charles River) were inoculated with 2 3 106 PFU per eye in a
volume of 5 ml following bilateral scarification of the cornea
with a 26-gauge needle. Eye swabs were routinely performed
24 h after infection, whereas trigeminal ganglia were ex-
planted at various times postinfection. Virus present in the eye
swabs and ganglion homogenates was detected by standard
plaque assays on Vero cell monolayers.
Latency and reactivation experiments were performed
on ganglia harvested approximately 30 days after infection,
as described in Leib et al. (1989). Reactivation of latent virus
was monitored by a cocultivation assay. DMSO was in-
cluded for some assays at a final concentration of 200 mM
in growth medium and was present during the 5-day incu-
bation period. Reactivatable virus was detected by plaque
formation on Vero cell monolayers.
Quantitative DNA PCR analyses
DNA was prepared from infected trigeminal ganglia
(three mice per virus) and the samples from all the ganglia
were pooled for each virus. DNA was prepared as de-
scribed in Coen (1990b) and the concentration estimated by
determining the UV absorbance at 260 nm. PCR reactions
were carried out essentially as described by Coen (1990b)
and Strelow and Leib (1995). The PCR conditions used and
the choice of the HSV-1 gene for amplification were inden-
tical to those described by Strelow and Leib (1995). The
analysis of the VP16 and adipsin PCR products following
gel electrophoresis, transfer to nylon membranes, and hy-
bridization to radioactively labeled oligonucleotide probes
were carried out according to protocols described in Coen
(1990a) and Katz et al. (1990). Quantitative analysis of the
PCR products on the filters was performed using a Phos-
phoimager (FUJIX BAS 1000).
Data presentation
Autoradiographs were scanned on a Umax Powerlook
II scanner. The images were scanned at 300 dots per
inch into Adobe Photoshop 3.0 and were transported as
PICT files into Microsoft Powerpoint for figure presenta-
tion and printing.
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